• SENSEX 73,694.89
    448.86 (+0.61%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,380.50 1,356.40(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • NSE
    1,795.00 1,878.00(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,176.50 1,108.20(%)
  • Billionbrains
    189.10 112.02(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    932.45 1,177.60(%)
  • Birlasoft Ltd
    351.80 473.75(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Adani Ports
    1,857.35 1,891.80(%)
  • Coromandel Inter
    1,734.65 2,496.10(%)
  • JSW Dulux
    286.50 374.67(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Moneyview
    52.44 65.43(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gennex Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Prudential
  • BSE Code : 14707.0
  • ISIN : INE509C01026
9.10 0 (2.48%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    8.80

  • Today’s High

    9.21

  • Open

    8.80

  • Perv Close

    8.88

  • 52W Low

    7.05

  • 52W High

    17.25

Key Indicators

  • P/E(TTM)

    13.38

  • Mar.Cap (₹Cr.)

    221.08

  • Div & Yield %

    0.00

  • Book Value(₹)

    8.98

  • Debt-Equity Ratio

    2.48

  • AGM Date

    28-Oct-2026

  • EPS

    0.68

  • P/E Ratio

    13.38

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    221.08

  • RONW (%)

    10.51

  • ROCE (%)

    13.64

Score Board

  • Equity (₹ in Cr.)

    24.29

  • BV (₹)

    9.00

  • Sales( ₹ in Cr.)

    119.86

  • NP (in Cr.)

    16.66

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    221.08

  • 52 Week High

    17.25

  • 52 Week Low

    7.05

  • Price BSE

    9.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    221.08

  • P/C Ratio

    12.40

  • P/E Ratio

    13.10

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 134.85 105.11 74.05 71.35 65.26 63.65
Excise Duty 14.99 10.53 7.25 6.25 4.05 4.00
Net Sales 119.86 94.58 66.80 65.10 61.21 59.65
Other Income 8.14 9.22 4.30 3.40 1.38 0.52
Stock Adjustments 9.29 0.70 2.44 7.00 1.91 -1.53
Total Income 137.29 104.50 73.54 75.50 64.50 58.64
EXPENDITURE :            
Raw Materials 97.98 67.30 41.94 48.14 41.23 35.18
Power and Fuel Cost 3.60 3.08 3.29 4.26 3.17 3.01
Employee Cost 6.67 6.42 6.05 7.71 6.97 7.21
Other Manufacturing Expenses 0.61 0.77 1.06 1.18 0.80 2.14
Selling and Administration Expenses 4.15 4.72 2.93 4.40 3.43 3.44
Miscellaneous Expenses 2.61 2.80 1.54 1.82 2.15 0.98
Employee Benefit Expenses 6.67 6.42 6.05 7.71 6.97 7.21
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 115.62 85.09 56.81 67.51 57.74 51.96
Operating Profit 21.67 19.41 16.73 7.99 6.76 6.68
Interest 2.47 1.58 1.16 1.23 0.88 0.74
Gross Profit 19.20 17.83 15.57 6.76 5.88 5.94
Depreciation 0.97 0.77 0.81 0.74 0.79 0.88
Profit Before Tax 18.23 17.06 14.76 6.02 5.09 5.06
Current Tax 1.90 2.97 3.05 1.59 1.32 1.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.21 0.05 -0.09 -0.14 -0.15 -0.25
Reported Net Profit 16.13 14.04 11.80 4.56 3.92 4.04
Extraordinary Items -0.53 -0.12 0.00 0.04 0.00 -0.28
Adjusted Net Profit 16.66 14.16 11.80 4.52 3.92 4.32
Adjustment below Net Profit 0.05 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 54.05 40.02 28.22 23.66 19.74 15.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 70.23 54.05 40.02 28.22 23.66 19.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.66 0.62 0.52 0.25 0.31 0.32
Earnings Per Share(Adj)-Unit Curr 0.66 0.62 0.52 0.25 0.30 0.31
Book Value 8.98 7.87 7.26 4.39 3.48 3.15
Book Value(Adj)-Unit Curr 8.98 7.87 7.26 4.39 3.32 3.00

Shareholding Pattern

  • Promoter Group

    23.63%

  • Public Share Holding

    76.37%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 56,591,874 23.29 56,591,874 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 48,300 0.02 48,300 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 765,450 0.32 765,450 1
Others 0 0.00 0 0
Sub Total 57,405,624 23.63 57,405,624 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 3,600 0.00 3,600 1
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,600 0.00 3,600 1
2] Non Institution
Bodies Corporate 33,944,036 13.97 33,942,036 229
Clearing Members 0 0.00 0 0
Directors of their Relatives 113,041 0.05 113,041 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 0 0.00 0 0
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 8,148,520 3.35 8,148,520 718
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 36,862,513 15.17 36,862,513 69
Individuals holding nominal share capital up to Rs. 1 lakh 99,924,936 41.13 97,907,606 80,392
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 7,584 0.00 7,584 3
Others 462,000 0.19 462,000 3
Sub Total 185,538,450 76.37 183,519,120 81,471
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 242,947,674 100.00 240,928,344 81,481

Company Background

Gennex Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Gennex Laboratories Ltd
  • BSE Code : 14707.0
  • ISIN : INE509C01026

  • Incorporation Year

    1990

  • Registered Office

    Survey No 133 Bollaram
    Jinnaram Mandal, Medak,
    Telangana-502325

  • Telephone

    91-8458-279406/279516

  • FAX

  • Chairman

    Arihant Baid

  • Managing Director

    Arihant Baid

  • Company Secretary

    DINESH KUMAR KEJRIWAL

  • Auditor

    R Pugalia & Co

  • Face Value

    1

  • Listing

    BSE

  • Registrar

    R & D Infotech Pvt Ltd
    7A Betala Road,
    1st Floor,
    Mumbai - Kolkata - 700 026

Gennex Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Gennex Lab. 9.10 128.00 134.85 13.79 9.52
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77